z-logo
open-access-imgOpen Access
The Promising Role of New Generation HDACis in Anti-Cancer Therapies
Author(s) -
Éric Hervouet
Publication year - 2018
Publication title -
ebiomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.596
H-Index - 63
ISSN - 2352-3964
DOI - 10.1016/j.ebiom.2018.05.014
Subject(s) - romidepsin , vorinostat , panobinostat , histone deacetylase , cancer research , hdac4 , histone deacetylase 2 , cancer , acetylation , hdac11 , histone , biology , chemistry , medicine , biochemistry , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom